SaveHealth explores the potential prescription cost savings that can be achieved by leveraging cash prices and discount cards, providing insights based on real-world drug pricing data.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and ...

The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and 14 other medications, a cost-saving move that would take effect in 2027.